rxstat › Classes › Antiinfectives

Antiinfectives: shortage status in Canada

9 of the 11 antiinfectives rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Gatifloxacin (Zymar) Widespread shortage 2 of 3 reported products affected · est. return Sep 4, 2026 Gentamicin Widespread shortage 2 of 2 reported products affected Erythromycin (Eryc Delayed-Release) Partial shortage 1 of 16 reported products affected Gramicidin Polymyxin B (Polytopic) Partial shortage 1 of 2 reported products affected Moxifloxacin (Avelox) Partial shortage 6 of 18 reported products affected · est. return Dec 31, 2026 Ofloxacin (Ocuflox) Partial shortage 1 of 2 reported products affected · est. return Jul 30, 2026 Polymyxin B Gramicidin Neomycin Partial shortage 1 of 1 reported products affected Sulfacetamide Partial shortage 1 of 1 reported products affected Trimethoprim Polymyxin B Partial shortage 1 of 1 reported products affected · est. return Aug 14, 2026 Trifluridine (Viroptic) Discontinued 0 of 1 reported products affected Trimethoprim Polymyxin B (Polytrim Ophthalmic) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.